Sökning: "Metabolic and endocrine effects of SGLT2 inhibition"
Hittade 1 avhandling innehållade orden Metabolic and endocrine effects of SGLT2 inhibition.
1. Metabolic and endocrine effects of SGLT2 inhibition
Sammanfattning : Obesity and type 2 diabetes (T2D) are two growing global health problems with similar comorbidity profiles. SGLT2 inhibitors (SGLT2i) improve blood glucose control and can relieve both T2D and obesity, as well as their associated health problems such as hypertension, kidney failure, and cardiovascular disease. LÄS MER
Resultatsidor:
1